Ayumu Taguchi

Ayumu Taguchi

UNVERIFIED PROFILE

Are you Ayumu Taguchi?   Register this Author

Register author
Ayumu Taguchi

Ayumu Taguchi

Publications by authors named "Ayumu Taguchi"

Are you Ayumu Taguchi?   Register this Author

50Publications

1307Reads

39Profile Views

Failure to Disclose Potential Conflict of Interest-Letter of Explanation.

JAMA Oncol 2019 Nov 14. Epub 2019 Nov 14.

Aichi Cancer Center, Nagoya, Aichi, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2019.5259DOI Listing
November 2019

Harnessing Immune Response to Malignant Lung Nodules. Promise and Challenges.

Am J Respir Crit Care Med 2019 May;199(10):1184-1186

3 Division of Pulmonary and Critical Care Medicine University of Michigan Ann Arbor, Michigan.

View Article

Download full-text PDF

Source
https://www.atsjournals.org/doi/10.1164/rccm.201811-2188ED
Publisher Site
http://dx.doi.org/10.1164/rccm.201811-2188EDDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6519851PMC
May 2019

HIV Infection and Circulating Levels of Prosurfactant Protein B and Surfactant Protein D.

J Infect Dis 2018 01;217(3):413-417

Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/infdis/jix510DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5853828PMC
January 2018

A statistical method for detecting differentially expressed SNVs based on next-generation RNA-seq data.

Biometrics 2017 03 8;73(1):42-51. Epub 2016 Jun 8.

Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/biom.12548DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5151178PMC
March 2017

Predictive and Prognostic Molecular Biomarkers for Response to Neoadjuvant Chemoradiation in Rectal Cancer.

Int J Mol Sci 2017 Mar 7;18(3). Epub 2017 Mar 7.

Departments of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://www.mdpi.com/1422-0067/18/3/573
Publisher Site
http://dx.doi.org/10.3390/ijms18030573DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372589PMC
March 2017

Deciphering the complexity of the cancer proteome for diagnostic applications.

Expert Rev Mol Diagn 2016 17;16(4):399-405. Epub 2016 Feb 17.

c Department of Pulmonary Medicine , University of Texas MD Anderson Cancer Center , Houston , Texas , US.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737159.2016.1135738DOI Listing
December 2016

Switching Roles of TGF-β in Cancer Development: Implications for Therapeutic Target and Biomarker Studies.

J Clin Med 2016 Nov 30;5(12). Epub 2016 Nov 30.

Department of Clinical Cancer Prevention, the University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/jcm5120109DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5184782PMC
November 2016

Serum Glycans as Risk Markers for Non-Small Cell Lung Cancer.

Cancer Prev Res (Phila) 2016 Apr 26;9(4):317-23. Epub 2016 Jan 26.

Department of Clinical Cancer Prevention - Research, Clinical Cancer Prevention, University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1940-6207.CAPR-15-0033DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4818659PMC
April 2016

Diacetylspermine Is a Novel Prediagnostic Serum Biomarker for Non-Small-Cell Lung Cancer and Has Additive Performance With Pro-Surfactant Protein B.

J Clin Oncol 2015 Nov 17;33(33):3880-6. Epub 2015 Aug 17.

William R. Wikoff, Brian DeFelice, and Oliver Fiehn, National Institutes of Health West Coast Metabolomics Center, University of California, Davis, Davis; Suzanne Miyamoto and David Gandara, University of California, Davis, Davis Comprehensive Cancer Center, Sacramento, CA; Samir Hanash, Yang Zhao, Ziding Feng, and Ayumu Taguchi, The University of Texas MD Anderson Cancer Center, Houston, TX; and Matt Barnett and Gary Goodman, Fred Hutchison Cancer Research Center, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.61.7779DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652011PMC
November 2015

MAPRE1 as a plasma biomarker for early-stage colorectal cancer and adenomas.

Cancer Prev Res (Phila) 2015 Nov 4;8(11):1112-9. Epub 2015 Sep 4.

Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1940-6207.CAPR-15-0077DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4633385PMC
November 2015

Carboxylesterase 2 as a Determinant of Response to Irinotecan and Neoadjuvant FOLFIRINOX Therapy in Pancreatic Ductal Adenocarcinoma.

J Natl Cancer Inst 2015 Aug 29;107(8). Epub 2015 May 29.

: Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX (MC, HW, SMH); Fred Hutchinson Cancer Research Center, Seattle, WA (ML, IB); Departments of Surgical Oncology (MHK, JBF), Pathology (AM, HW, WT), and Translational Molecular Pathology (AM, HW, AT, SMH), The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djv132DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554193PMC
August 2015

Proteomic signatures associated with p53 mutational status in lung adenocarcinoma.

Proteomics 2014 Dec 20;14(23-24):2750-9. Epub 2014 Nov 20.

Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pmic.201400378DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4403731PMC
December 2014

Mouse to human blood-based cancer biomarker discovery strategies.

Cold Spring Harb Protoc 2014 Feb 1;2014(2):144-9. Epub 2014 Feb 1.

M.D. Anderson Cancer Center, Houston, Texas 77030.

View Article

Download full-text PDF

Source
http://www.cshprotocols.org/lookup/doi/10.1101/pdb.top078808
Publisher Site
http://dx.doi.org/10.1101/pdb.top078808DOI Listing
February 2014

Pro-surfactant protein B as a biomarker for lung cancer prediction.

J Clin Oncol 2013 Dec 18;31(36):4536-43. Epub 2013 Nov 18.

Don D. Sin, Stephen Lam, and Anthony Tam, University of British Columbia; Don D. Sin and Anthony Tam, Institute of Heart and Lung Health, James Hogg Research Center, St. Paul's Hospital; Stephen Lam and Xiaobo Duan, British Columbia Cancer Agency, Vancouver, British Columbia; C. Martin Tammemagi, Brock University, St. Catharines, Ontario, Canada; Matt J. Barnett, Ziding Feng, and Gary E. Goodman, Fred Hutchinson Cancer Research Center, Seattle, WA; Heidi Auman, Canary Foundation, Palo Alto, CA; and Ziding Feng, Samir Hanash, and Ayumu Taguchi, University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2013.50.6105
Publisher Site
http://dx.doi.org/10.1200/JCO.2013.50.6105DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3871515PMC
December 2013

CDKN2A/p16 inactivation mechanisms and their relationship to smoke exposure and molecular features in non-small-cell lung cancer.

J Thorac Oncol 2013 Nov;8(11):1378-88

*Hamon Center for Therapeutic Oncology Research and †Division of Biostatistics, University of Texas Southwestern Medical Center, Dallas, Texas; ‡Department of Integrative Oncology, British Columbia Cancer Agency Research Centre, Vancouver, B.C., Canada; §Texas Scottish Rite Hospital for Children, Dallas, Texas; ‖Department of Surgery, Biochemistry, and Molecular Biology, Keck School of Medicine, USC/Norris Comprehensive Cancer Center, Los Angeles, California; ¶Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; #Oncology Biomarker Development, Genentech Inc., South San Francisco, California; **Department of Molecular and Cell Biology, Center for Systems Biology, University of Texas at Dallas, Dallas, Texas; and ††Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e3182a46c0cDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3951422PMC
November 2013

Enrichment strategies in glycomics-based lung cancer biomarker development.

Proteomics Clin Appl 2013 Oct 6;7(9-10):664-76. Epub 2013 Aug 6.

Division of Hematology and Oncology, University of California Davis Comprehensive Cancer Center, Sacramento, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/prca.201200131DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3884000PMC
October 2013

Circulating pro-surfactant protein B as a risk biomarker for lung cancer.

Cancer Epidemiol Biomarkers Prev 2013 Oct 29;22(10):1756-61. Epub 2013 Jul 29.

Authors' Affiliations: Department of Clinical Cancer Prevention, University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Epidemiology, Biostatistics, and Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, New York; Divisions of Preventive Medicine and Aging, Department of Medicine, Brigham and Women's Hospital; and Boston VA Medical Center, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-13-0251DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3866965PMC
October 2013

Unleashing the power of proteomics to develop blood-based cancer markers.

Clin Chem 2013 Jan 24;59(1):119-26. Epub 2012 Oct 24.

Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1373/clinchem.2012.184572DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5939937PMC
January 2013

Application of proteomics to cancer early detection.

Cancer J 2011 Nov-Dec;17(6):423-8

Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PPO.0b013e3182383cabDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4318261PMC
June 2012

Comprehensive proteomic profiling of aldehyde dehydrogenases in lung adenocarcinoma cell lines.

Int J Proteomics 2011 29;2011:145010. Epub 2011 Oct 29.

Molecular Diagnostics Program, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, M5-C800, Seattle, WA 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2011/145010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3205746PMC
November 2011

P53, p21, and p73 gene polymorphisms in gastric carcinoma.

Hepatogastroenterology 2010 Nov-Dec;57(104):1595-601

Department of Gastroenterology, Nagoya University Graduate School of Medicine, 65 Tsuruma-cho, Showa-ku, Nagoya, Japan.

View Article

Download full-text PDF

Source
April 2011

The grand challenge to decipher the cancer proteome.

Nat Rev Cancer 2010 09;10(9):652-60

Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, M5-C800, PO BOX 19024, Seattle, Washington 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrc2918DOI Listing
September 2010

Detailed characterization of a homozygously deleted region corresponding to a candidate tumor suppressor locus at 21q11-21 in human lung cancer.

Genes Chromosomes Cancer 2008 Sep;47(9):810-8

Division of Molecular Carcinogenesis, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, Showa-ku, Nagoya, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.20582DOI Listing
September 2008

Identification of hypoxia-inducible factor-1 alpha as a novel target for miR-17-92 microRNA cluster.

Cancer Res 2008 Jul;68(14):5540-5

Division of Molecular Carcinogenesis, Center for Neurological Diseases and Cancer, Department of Gastroenterology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-07-6460DOI Listing
July 2008

Rugal hyperplastic gastritis increases the risk of gastric carcinoma, especially diffuse and p53-independent subtypes.

Eur J Gastroenterol Hepatol 2007 Jul;19(7):561-6

Department of Gastroenterology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MEG.0b013e32811ec056DOI Listing
July 2007

Lineage-specific dependency of lung adenocarcinomas on the lung development regulator TTF-1.

Cancer Res 2007 Jul;67(13):6007-11

Division of Molecular Carcinogenesis, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, Nagoya, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-06-4774DOI Listing
July 2007

MDM2 promoter polymorphism is associated with both an increased susceptibility to gastric carcinoma and poor prognosis.

J Clin Oncol 2006 Sep;24(27):4434-40

Department of Gastroenterology, Nagoya University Graduate School of Medicine, Nagoya, Japan 466-8550;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.04.1459DOI Listing
September 2006

Interleukin-8 gene polymorphism associated with susceptibility to non-cardia gastric carcinoma with microsatellite instability.

J Gastroenterol Hepatol 2006 Jul;21(7):1129-35

Division of Gastroenterology, Department of Therapeutic Medicine, Nagoya University School of Medicine, Nagoya, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1440-1746.2006.04443.xDOI Listing
July 2006

Severity of atrophic gastritis related to antiparietal cell antibody and gastric carcinogenesis, including p53 mutations.

J Gastroenterol Hepatol 2006 Mar;21(3):545-51

Division of Gastroenterology, Department of Therapeutic Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1440-1746.2005.03983.xDOI Listing
March 2006

Interleukin-8 promoter polymorphism increases the risk of atrophic gastritis and gastric cancer in Japan.

Cancer Epidemiol Biomarkers Prev 2005 Nov;14(11 Pt 1):2487-93

Division of Gastroenterology, Department of Therapeutic Medicine, Nagoya University Graduate School of Medicine, 65 Tsuruma-cho, Showa-ku, Nagoya, Aichi, 466-8550 Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-05-0326DOI Listing
November 2005